TrialFind
Saved trials
Back to results
Completed
Phase 3
Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus
NCT02489968
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Tokai Memorial Hospital
Aichi, Kasugai, Japan
+82 additional locations
View on ClinicalTrials.gov
Official details